Aqua Science is asking for $50,000 from the state as part of the Delaware Technical Innovation Program. (Photo from Aqua Science website)

Aqua Science asks for state-funded bridge grant to support growth to $6.8M revenue in 2029

Jarek RutzHeadlines, Business

NEWARK – Aqua Science, a women-owned business led by Iwona Evans, is asking the state to provide a grant to help it take off from a long development runway. It is seeking $50,000 from the Council on Development Finance, part of the Delaware Economic Development Authority’s Division of Small Business, at its Dec. 9 meeting. The company, founded in 2020 …

Iwana Evans founded Aqua Science in 2020.

Aqua Science Owner Iwona Evans survived a career pivot and pandemic launch

Jarek RutzHeadlines, Business

When Iwona Evans moved to the United States from Szczecin, Poland, in 2000, she expected to be here for only a year. Twenty-four years, three college degrees, and lots of experience as a finance executive later, she’s running a biotech company that aims to ensure humans, animals, and plants have safe and clean water and helps clients meet stricter environmental …

FFI Ionix Hydrogen

Decarbonization, hydrogen company expands in Kent County

Betsy PriceBusiness, Headlines

An international company has chosen a site in Kent County to base its operations to support global decarbonization and the hydrogen economy. FFI Ionix will move from its 15,000-square-foot site in Harrington to 60 Starlifter Ave. in Dover . More than 22,000 square feet of the new facility’s $57,000 square feet will be lab space. The site will be the …

Uvax Bio nanoparticle display platform

Vaccine company Uvax Bio sets $8M expansion in Delaware

Betsy PriceBusiness, Headlines

  A Newark vaccine company will spend $8 million to expand in Delaware, adding 63 jobs over the next three years. Uvax Bio, considered an early stage biopharmaceutical company with cutting-edge vaccine platform technology, has been headquartered in Newark since 2018. where it has five employees. Its platform has produced both COVID-19 and HIV-1 vaccine candidates. The new positions will …